Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
Neuropediatrics|April 1, 1993
Dystrophin expression in Duchenne patients with "in-frame" gene deletionsL V Nicholson, K M Bushby, M A Johnson, et al.Journal of the Neurological Sciences|August 1, 1993
Immunohistological evidence for second or somatic mutations as the underlying cause of dystrophin expression by isolated fibres in Xp21 muscular dystrophy of Duchenne-type severityC Wallgren-Pettersson, B Jasani, L G Rosser, et al.Acta Neurologica Scandinavica|July 1, 1992
Dystrophin or a "related protein" in Duchenne muscular dystrophy?L V Nicholson, M A Johnson, K Davison, et al.Journal of the Neurological Sciences|December 1, 1989
Dystrophin in skeletal muscle. I. Western blot analysis using a monoclonal antibodyL V Nicholson, K Davison, G Falkous, et al.Neuromuscular Disorders : NMD|January 1, 1993
Variability in clinical, genetic and protein abnormalities in manifesting carriers of Duchenne and Becker muscular dystrophyK M Bushby, J A Goodship, L V Nicholson, et al.Journal of Clinical & Laboratory Immunology|May 1, 1981
Acetylcholine receptor antibody synthesis in lymphocyte culturesS M McLachlan, L V Nicholson, G Venables, et al.Neuromuscular Disorders : NMD|March 1, 1993
Sarcolemmal distribution of abnormal dystrophin in Xp21 carriersM Vainzof, L V Nicholson, D E Bulman, et al.Journal of Medical Genetics|December 1, 1992
Predicted and observed sizes of dystrophin in some patients with gene deletions that disrupt the open reading frameL V Nicholson, K M Bushby, M A Johnson, et al.Journal of the Neurological Sciences|February 1, 1992
A homologue of dystrophin is expressed at the blood vessel membrane of DMD and BMD patients: immunological evidenceN Augier, J Boucraut, J Léger, et al.Neuromuscular Disorders : NMD|January 1, 1991
Immunogold labelling of dystrophin in human muscle, using an antibody to the last 17 amino acids of the C-terminusM J Cullen, J Walsh, L V Nicholson, et al.Pageof 5